Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Semperit raises annual guidance after strong Q2 EBITDA to around €100m
Semperit expects reported EBITDA for Q2 2026 of about €40m (Q2 2025: €19.6m) and H1 EBITDA of around €67m (H1 2025: €30.7m). Before project costs of about €5m, operating EBITDA for 2026 is now expected to be roughly €100m, previously forecast at around €95m. The company cites continued significant uncertainty due to the war in the Middle East. The half‑year results will be published on 13 August 2026. » More on de.investing.com
B&C increases stake in Semperit to around 63.4% after voluntary takeover offer
B&C Holding Österreich received acceptances for 1,022,192 Semperit shares under the voluntary public offer by 12 June 2026 and, after settlement, will hold about 63.4% of the ordinary shares. The suspensive condition has been met; a three‑month extension will not be applied. The settlement of the offer will take place no later than 26 June 2026; the result will be published on the websites of the parties involved and the Takeover Commission. » More on finanzen.net
Semperit expects Q1 EBITDA well above last year, full-year forecast unchanged
Semperit forecasts EBITDA of around EUR 26 million for Q1 2026 (Q1 2025: EUR 11.1 million), roughly in line with Q4 2025. The full-year guidance remains unchanged at an operating EBITDA of around EUR 95 million (before project costs of around EUR 5 million). Geopolitical uncertainties could dampen demand in the second half of the year; potential raw material shortages are not included in the forecast. Q1 results will be published on 13 May 2026. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFundamentals
| Metric | Value |
|---|---|
Market capitalization | 0.00€ |
52-week high/low | 34,30€ - 27,04€ |
| Dividends | No |
Beta | 0,32 |
P/E ratio | - |
PEG ratio | - |
P/B ratio | - |
P/S ratio | - |
Company profile
Die Semperit Aktiengesellschaft Holding entwickelt, produziert und vertreibt weltweit Kautschukprodukte für den medizinischen und industriellen Sektor. Das Unternehmen ist in fünf Segmenten tätig: Sempermed, Semperflex, Sempertrans, Semperform und Semperseal. Das Segment Sempermed stellt Untersuchungs- und Operationshandschuhe für den medizinischen Bereich sowie Schutzhandschuhe für den industriellen, gewerblichen und privaten Gebrauch her. Das Segment Semperflex entwickelt, produziert und vertreibt Hydraulik- und Industrieschläuche, die in der Bau- und Transportindustrie sowie im Bergbau und bei landwirtschaftlichen Maschinen eingesetzt werden. Das Segment Sempertrans bietet Textil- und Stahlseilfördergurte für den Einsatz in der Bergbau-, Stahl-, Zement-, Tiefbau- und Transportindustrie sowie in Kraftwerken an. Das Segment Semperform bietet Handläufe für Rolltreppen, Gummiringe für Seilbahnen, Antivibrationsmembranen für Skier und Snowboards sowie kundenspezifische Spritzguss- und Extrusionsteile mit Dichtungs- oder Dämpfungsfunktion. Das Segment Semperseal bietet Elastomer- und Dichtungsprofile für Fenster, Türen und Fassaden sowie elastomere und verschleißfeste Schutzfolien. Das Unternehmen wurde 1824 gegründet und hat seinen Hauptsitz in Wien, Österreich.
| Name | Semperit |
| Headquarters | Copenhagen,
Austria |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 12/04/2019 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Vie | SEM.VI |
XETRA | SEW.DE |
DĂĽsseldorf | SEW.DU |
Frankfurt | SEW.F |
London | 0G29.L |
MĂĽnchen | SEW.MU |
Wien | SEM.VI |
Pnk | PALAF |
Nasdaq Copenhagen | DKIDKIEXOMXC20D.CO |
London Stock Exchange | UC98.L |
Discover assets
Shareholders of Semperit also invest in the following assets
